Citric Acid

Citric Acid

SCHEMBL215569

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Zr+4].[Zr+4].[Zr+4]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.89
ALDH1A1 P00352 1/20 0.33
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL891608 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL31746086 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL28539693 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL4441601 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL8813383 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL9551398 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL9551548 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL226551 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL1291555 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL22686437 0.97 CA4 (0.94) CA4ALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1755 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121736172-B Composition for controlled release type ultrahigh temperature resistant salt resistant gel, preparation method and application thereof 中国石油大学(北京) 2026-05-19 CN claimed
CN-119391396-B Oil-free phase resistance reducing agent for fracturing fluid and preparation method thereof 中石化石油工程技术服务股份有限公司 2026-05-15 CN claimed
CN-122011276-A Oil reservoir deep profile control and flooding combined particle, and preparation method and application thereof 中海石油(中国)有限公司天津分公司 2026-05-12 CN claimed
US-20260042710-A1 METHOD FOR PRODUCING ZIRCONIA POWDER CONTAINING MULTIPLE RARE EARTH ELEMENTS NAT CHUNG SHAN INST SCIENCE & TECH (TW) 2026-02-12 US claimed
US-12371444-B2 Methods of making MOFs, systems for synthesizing MOFs, and methods of coating textiles with MOFs UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2025-07-29 US claimed
CN-119368161-B Core-shell structure three-way catalyst for reducing automobile exhaust emission and preparation method thereof 东华大学 2025-05-16 CN claimed
CN-119455920-B Dual-functional fluorescent probe adsorption material and preparation method and application thereof 合肥科环环境科技股份有限公司 2025-05-09 CN claimed
CN-119909740-A Multilayer core-shell structure catalyst, preparation method and application thereof in synthesizing 1, 3-propylene glycol from glycerol 中国石油化工股份有限公司 2025-05-02 CN claimed
CN-119912932-A Fracturing fluid system for compact limestone, preparation method and application thereof 中国石油天然气股份有限公司 2025-05-02 CN claimed
CN-119542484-B Slurry type manganese positive electrode electrolyte for flow battery 浙江师范大学 2025-04-18 CN claimed
WO-1997022638-A1 COMPOSITIONS AND PROCESSES FOR TREATING SUBTERRANEAN FORMATIONS PHILLIPS PETROLEUM COMPANY (US) 1997-06-26 WO claimed
US-5614475-A CROSSLINKED WITH ZIRCONIUM, VISCOSITY STABILTY AT HIGH TEMPERATURE RHONE-POULENC INC. (US) 1997-03-25 US claimed
WO-1996034179-A1 CARBOXYALKYL SUBSTITUTED POLYGALACTOMANNAN FRACTURING FLUIDS RHONE-POULENC INC. (US) 1996-10-31 WO claimed
US-5547025-A INJECTING A GELLING COMPOUND PHILLIPS PETROLEUM COMPANY (US) 1996-08-20 US claimed
EP-0668432-A2 Process for treating oil-bearing formation PHILLIPS PETROLEUM COMPANY (US) 1995-08-23 EP claimed
US-5423380-A Adding crosslinking agent intermittently to stream of aqueous solution of gellable polymer injected into subterranean formation PHILLIPS PETROLEUM COMPANY (US) 1995-06-13 US claimed
EP-0549156-A1 Process for oligomerizing olefins using titanium salts or zirconium salts deposited on silicon dioxide TEXACO CHEMICAL COMPANY (US) 1993-06-30 EP claimed
EP-0524733-A1 Process for oligomerizing olefins using halogen-free titanium salts or halogen-free zirconium salts on clays TEXACO CHEMICAL COMPANY (US) 1993-01-27 EP claimed
US-5146030-A Synthetic lubricants TEXACO CHEMICAL COMPANY (US) 1992-09-08 US claimed
US-3966502-A Zirconium rinse for phosphate coated metal surfaces AMCHEM PRODUCTS, INC. (US) 1976-06-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042710-A1 METHOD FOR PRODUCING ZIRCONIA POWDER CONTAINING MULTIPLE RARE EARTH ELEMENTS ZRANB2, SON, PIEZO1 CA4 95/4885ALDH1A1 4803/4885CASP1 2732/4885
US-12371444-B2 Methods of making MOFs, systems for synthesizing MOFs, and methods of coating textiles with MOFs PIEZO1, CUTA, MASTL CA4 31/4885ALDH1A1 2709/4885CASP1 1463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.